[Dysmorphophobia (body dysmorphic disorder)].

This article reviews the historical and terminological origins of dysmorphophobia from Herodotus to today. It explains the differences pointed out by many authors, including the DSM-III-R, between body dismorphic disorder and delusional disorder somatic type, which are referred to as monosymptomatic hypochondriacal psychoses in Europe. Epidemiological data, clinical characteristics and outcome are discussed. Explicative theories and neurobiological, developmental and analytical aspects of body image are presented. The association between body dismorphic disorder and other disorders is analyzed, and treatment possibilities are discussed. The authors suggest that body dismorphic disorder be classified with obsessive compulsive disorder, whatever the intensity of symptomatology, rather than with somatoform or delusional disorder, and treated with serotonin uptake inhibitors or neureptics that have been proven to be effective for the treatment of this disorder, such as pimozide.
AuthorsM J Filteau, E Pourcher, P Baruch, R H Bouchard, P Vincent
JournalCanadian journal of psychiatry. Revue canadienne de psychiatrie (Can J Psychiatry) Vol. 37 Issue 7 Pg. 503-9 (Sep 1992) ISSN: 0706-7437 [Print] CANADA
Vernacular TitleLa dysmorphophobie (trouble dysmorphique physique).
PMID1423148 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Serotonin Uptake Inhibitors
  • Pimozide
  • Body Image
  • Delusions (diagnosis, drug therapy, epidemiology)
  • Humans
  • Obsessive-Compulsive Disorder (diagnosis, drug therapy, epidemiology)
  • Pimozide (therapeutic use)
  • Prevalence
  • Serotonin Uptake Inhibitors (therapeutic use)
  • Terminology as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: